CGI
NVRO

Comgest Global Investors’s NEVRO CORP. NVRO Stock Holding History

Comgest Global Investors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-36,200
Closed -$1.41M – 53
2018
Q4 		$1.41M Hold
36,200
– – 0.03% 48
2018
Q3 		$2.06M Sell
36,200
-8,200
-18% -$513K 0.05% 47
2018
Q2 		$3.55M Hold
44,400
– – 0.08% 42
2018
Q1 		$3.85M Buy
44,400
+5,000
+13% +$404K 0.08% 41
2017
Q4 		$2.72M Buy
+39,400
New +$3.15M 0.06% 49

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Comgest Global Investors's NVRO Position: Q1 2019 in Review

Comgest Global Investors sold out of NEVRO CORP. (NVRO) in Q1 2019, closing a stake of 36,200 shares — an estimated $1.41M sold.

Comgest Global Investors first reported a position in NVRO in Q4 2017 and held it in 5 quarters. The position peaked at $3.85M in Q1 2018. 172 funds tracked by Wall St. Rank hold NVRO as of Q1 2019.

  • Comgest Global Investors reported no remaining NEVRO CORP. position as of Q1 2019 after selling out during the quarter.
  • Comgest Global Investors sold 36,200 NEVRO CORP. shares in Q1 2019, an estimated $1.41M.
  • Comgest Global Investors first reported a position in NEVRO CORP. in Q4 2017 and held it in 5 quarters.
  • Comgest Global Investors's NEVRO CORP. position peaked at $3.85M in Q1 2018.
  • 172 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2019.

Based on Comgest Global Investors's 13F filing for Q1 2019, filed 9 May 2019.